Abstract N6-methyladenosine (m6A) is considered the most common, abundant, and
conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA) …

Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …

Background Platinum-based concurrent chemoradiotherapy is the standard of care for
patients with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine …

Background Patients with locoregionally advanced nasopharyngeal carcinoma have a high
risk of disease relapse, despite a high proportion of patients attaining complete clinical …

Long noncoding RNAs (lncRNA) play important roles in the tumorigenesis and progression
of cancers. However, the clinical significance of lncRNAs and their regulatory mechanisms …

Background The value of adding cisplatin, fluorouracil, and docetaxel (TPF) induction
chemotherapy to concurrent chemoradiotherapy in locoregionally advanced …

Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …

Purpose: We aimed to evaluate the value of deep learning on positron emission tomography
with computed tomography (PET/CT)–based radiomics for individual induction …

Background The aim of this trial was to address whether elective ipsilateral upper-neck
irradiation (UNI) sparing the uninvolved lower neck provides similar regional relapse-free …

Purpose Target delineation in nasopharyngeal carcinoma (NPC) often proves challenging
because of the notoriously narrow therapeutic margin. High doses are needed to achieve …